Mail-order access to mifepristone, a Federal Drug Administration-approved abortion pill, would no longer be available, based on a ruling of the U.S. Court of Appeals for the Fifth Circuit.
Circuit Judge Jennifer Walker Elrod delivered the ruling Wednesday in Alliance for Hippocratic Medicine v. Food & Drug Administration, vacating a district court order in part and affirming in part.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
